Trial Profile
Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 07 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 25 Jan 2013 Planned end date changed from 1 Mar 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 03 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.